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Temporal Effect of Adrenocorticotrophic Hormone on Adrenal
Glucocorticoid Steroidogenesis: Involvement of the Transducer of
Regulated Cyclic AMP-Response Element-Binding Protein Activity
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The hypothalamic-pituitary-adrenal (HPA) axis is a neuroendocrine
system that shows diurnal variation and is activated by stress to
maintain homeostasis. Its activity is regulated by a feedforward
mechanism involving the release of neuropeptides (corticotrophin-
releasing hormone and vasopressin) from the paraventricular
nucleus of the hypothalamus, which in turn stimulates anterior
pituitary corticotrophs to secrete adrenocorticotrophic hormone
(ACTH). ACTH subsequently induces glucocorticoid synthesis in the
zona fasciculata of the adrenal cortex. Newly synthesised glucocor-
ticoids are then released into the circulation to regulate a broad
range of physiological processes, including metabolic and cardiovas-
cular functions, immune response and behaviour.
Adrenal steroidogenesis is activated by the binding of ACTH to
the speciﬁc melanocortin type-2 receptor (MC2R), cell surface
seven-transmembrane domain G-protein-coupled receptor. Upon
ACTH binding, MC2R undergoes conformational changes that acti-
vate adenylyl cyclase, leading to an increase in intracellular levels
of cyclic AMP (cAMP) and subsequent activation of protein kinase
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The availability of active steroidogenic acute regulatory protein (StAR) and side-chain cleavage
cytochrome P450 (P450scc) are rate-limiting steps for steroidogenesis. Transcription of StAR and
P450scc genes depends on cyclic AMP-response element-binding protein (CREB) phosphorylation
and CREB co-activator, transducer of regulated CREB activity (TORC), which is regulated by salt-
inducible kinase 1 (SIK1). In the present study, we investigated the relationship between TORC
activation and adrenocorticotrophic hormone (ACTH)-induced steroidogenesis in vivo, by examin-
ing the time-course of the effect of ACTH injection (4 ng, i.v.) on the transcriptional activity of
StAR and P450scc genes and the nuclear accumulation of transducer of regulated CREB activity
2 (TORC2) in rat adrenal cortex. ACTH produced rapid and transient increases in plasma cortico-
sterone, with maximal responses between 5 and 15 min, and a decrease to almost basal values
at 30 min. StAR and P450scc hnRNA levels increased 15 min following ACTH and decreased
toward basal values at 30 min. Concomitant with an increase in nuclear phospho-CREB, ACTH
injection induced nuclear accumulation of TORC2, with maximal levels at 5 min and a return to
basal values by 30 min. The decline of nuclear TORC2 was paralleled by increases in SIK1 hnRNA
and mRNA 15 and 30 min after injection, respectively. The early rises in plasma corticosterone
preceding StAR and P450scc gene transcription suggest that post-transcriptional and post-
translational changes in StAR protein mediate the early steroidogenic responses. Furthermore,
the direct temporal relationship between nuclear accumulation of TORC2 and the increase in
transcription of steroidogenic proteins, implicates TORC2 in the physiological regulation of ste-
roidogenesis in the adrenal cortex. The delayed induction of SIK1 suggests a role for SIK1 in the
declining phase of steroidogenesis.
Key words: adrenal glands, steroidogenesis, ACTH, transducer of regulated CREB activity 2
(TORC2), salt-inducible kinase 1 (SIK1).
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From Molecular to Translational NeurobiologyA (PKA). Activation of PKA results in phosphorylation of cAMP-
response element-binding protein (CREB), which binds to cAMP
response elements (CRE) and induces gene transcription and syn-
thesis of steroidogenic proteins.
Two proteins are of crucial importance in the acute induction of
steroidogenesis from the precursor, cholesterol: (i) steroidogenic
acute regulatory protein (StAR), which regulates the mobilisation of
cholesterol and its transfer from the outer to the inner mitochon-
drial membrane (1, 2), and (ii) cholesterol side-chain cleavage cyto-
chrome P450 (P450scc), which catalyses the cleavage of the
cholesterol side chain to produce pregnenolone in the inner mito-
chondrial membrane (3). In contrast to peptide hormones, which, in
basal conditions, are stored within the cytoplasm and released upon
activation, glucocorticoids are synthesised de novo following ACTH-
mediated stimulation of the adrenal. As glucocorticoids are released
in a pulsatile manner with an hourly rhythm (4), glucocorticoid
synthesis must be rapid and highly dynamic. Although it is clear
that this pulsatility is important for glucocorticoid signalling (5, 6),
surprisingly little is known about the mechanism underlying the
pulsatile synthesis of glucocorticoids.
Transcriptional regulation of several CREB-inducible genes
requires the activation by dephosphorylation and nuclear transloca-
tion of the CREB co-activator transducer of regulated CREB activity
(TORC, also known as CRTC) (7–10). In basal conditions, transducer
of regulated CREB activity 2 (TORC2) is sequestered in the cyto-
plasm in an inactive phosphorylated state by salt-inducible kinase 1
(SIK1) and other AMP-activated protein kinases (10, 11). It has been
shown that inactivation of SIK1 by PKA allows dephosphorylation
and nuclear translocation of TORC and consequent CREB dependent
transcriptional activation. The TORC⁄SIK system has been implicated
in adrenal regulation (12). SIK1 is present in the adrenals and stud-
ies in cell lines have shown that its inhibition by the protein kinase
inhibitor staurosporin induces StAR and steroidogenic enzymes (13).
The ﬁnding that SIK1 is responsible for TORC phosphorylation sug-
gests that TORC is involved in the transcriptional regulation of the
steroidogenic proteins (13).
In the present study, we have investigated the dynamics of glu-
cocorticoid synthesis induced by a pulse of ACTH in vivo by mea-
suring the time-dependent changes in transcription of StAR and
P450 genes. Furthermore, in light of the importance of TORC2 and
SIK1 in the regulation of steroidogenesis, the effect of ACTH was
investigated on nuclear accumulation of TORC2 and on the tran-
scription of the SIK1 gene.
Materials and methods
Animals
All experiments were conducted on adult male Sprague-Dawley rats (Harlan,
Oxon, UK) weighing 250–300 g at the time of surgery. Animals were
grouped housed four in each cage and allowed to acclimatise to the hous-
ing facility for a minimum of 1 week before the start of the experiment.
Rats were maintained under standard environmental conditions (21  1  C)
under a 14 : 10 h light⁄dark cycle (lights on 05.15 h) and food and water
were provided ad lib. throughout the experiment. All animal procedures were
approved by the University of Bristol Ethical Review Group and were con-
ducted in accordance with Home Ofﬁce guidelines and the UK Animals (Sci-
entiﬁc Procedures) Act, 1986.
Surgery
Animals were anaesthetised with a combination of Hypnorm (0.32 mg⁄kg
fentanyl citrate and 10 mg⁄kg ﬂuanisone, i.m.; Janssen Pharmaceuticals,
Oxford, UK) and diazepam (2.6 mg⁄kg i.p.; Phoenix Pharmaceuticals,
Gloucester, UK). Intravenous cannulation of the jugular vein was performed
as previously described (14). The right jugular vein was exposed and a silas-
tic-tipped (Merck Whitehouse, NJ, USA) polythene cannula (Portex, Hythe,
UK), pre-ﬁlled with pyrogen-free heparinised (10 IU⁄ml) isotonic saline, was
inserted into the vessel for ACTH administration. The free end of the can-
nula was exteriorised through a scalp incision and then tunnelled through a
protective spring that was anchored to the parietal bones using two stain-
less steel screws and self-curing dental acrylic. The end of the protective
spring was attached to a mechanical swivel that rotated through 360  in a
horizontal plane and 180  through a vertical plane, allowing the rats to
maximise freedom of movement. Following recovery from the anaesthesia,
animals were housed in individual cages and left to recover for 5 days
before starting the experiments. The cannula was ﬂushed daily with the
heparinised saline to maintain patency.
Experimental procedures
Experiments started on day 5 after surgery at 14.00 h. To suppress endoge-
nous ACTH secretion, rats were treated with the synthetic glucocorticoid
methylprednisolone sodium succinate (250 mg, i.v., Solu-Medrone; Pharma-
cia, Sandwich, UK). This dose has been shown to inhibit corticosterone
secretion within 30 min from injection and its effects last for over 5 h (15).
Two hours after methylprednisolone injection, rats were treated with syn-
thetic ACTH (Synacthen, [ACTH-(1–24)] fragment, 4 ng⁄0.1 ml, i.v.; Alliance
Pharmaceutical, Chippenham, UK). Rats were overdosed with 0.5 ml of
sodium pentobarbital (Euthatal, 200 mg⁄ml; Merial, Harlow, UK) before
ACTH injection (t0) or 5, 15, 30 and 60 min (t5–t60) after ACTH administration.
Trunk blood was collected on ice into tubes containing 50 ll of ethylen-
ediaminetetraacetic acid (0.5 M; pH 7.4) and 50 ll of Aprotinin
(500 000 KIU⁄ml, Trasylol; Bayer, EDTA, Newbury, UK). Plasma was separated
by centrifugation and then stored at )80  C until processed for corticoste-
rone and ACTH measurements. Adrenal glands were collected and quickly dis-
sected free of fat and decapsulated to separate the outer capsule containing
the zona glomerulosa and the inner zones comprising the zona fasciculata
and zona reticularis of the cortex and the medulla. Individual inner zones
were immediately frozen in dry ice until processing for isolation of RNA for a
reverse transcription quantitative polymerase chain reaction (RT-qPCR) (left
adrenal) and protein extraction for western blotting (right adrenal).
Hormone measurements
Total plasma corticosterone was measured by radioimmunoassay (RIA) using
a citrate buffer (pH 3.0) to denature the binding globulin as previously
described. Antisera was kindly supplied by Professor Gabor Makara (Institute
of Experimental Medicine, Budapest, Hungary) and [
125I] corticosterone was
purchased from Izotop (Budapest, Hungary). The intra- and inter-assay coef-
ﬁcients of variation of the corticosterone assay were 14.1% and 15.3%,
respectively.
ACTH in plasma was measured using 100 ll of plasma and RIA kit
reagents (DiaSorin, Stillwater, MN, USA) in accordance with the manufac-
turer’s instructions. This assay was chosen for its ability to equally recognise
ACTH 1–24 and 1–39. The intra- and inter-assay coefﬁcients of variation of
the ACTH assay were 2.2% and 7.8%, respectively.
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RNA isolation and RT-qPCR
Total RNA was extracted from the inner zone of individual adrenals using
TRIzol reagent (Invitrogen, Hopkinton, MA, USA), followed by puriﬁcation
using RNeasy mini kit reagents and column DNase digestion (Qiagen, Valen-
cia, CA, USA) to remove genomic DNA contamination. Complementary DNA
was reverse transcribed from 0.7 to 1 lg of total RNA as previously
described (16). Primary transcript and mRNA accumulation of StAR, P450scc
and SIK1 genes were evaluated using primer sequences designed to amplify
nascent RNA (hnRNA) and mature RNA (mRNA) respectively, as shown in
Table 1. Power SYBR green PCR mix (Applied Biosystems, Foster City, CA,
USA) was used for the ampliﬁcation mixture with each primer at a ﬁnal
concentration of 200 nM and 1.5 ll of cDNA for a total reaction volume of
12.5 ll. PCR reactions were performed on spectroﬂuorometric thermal
cycler7900 HT Fast Real-Time PCR System; Applied Biosystems) as described
previously (16). Samples were ampliﬁed by an initial denaturation at 50  C
for 2 min, 95  C for 10 min and then cycled (45 times) using 95  C for
15 s and 60  C for 1 min. StAR, P450scc and SIK1 hnRNA and mRNA levels
were normalised to glyceraldehyde 3-phosphate dehydrogenase mRNA as
determined in a separate real-time PCR reaction. The absence of RNA detec-
tion when the reverse transcription step was omitted indicated the lack of
genomic DNA contamination in the RNA samples.
Western blotting
Nuclear extracts from the inner zone of individual adrenals were prepared
using NE-PER nuclear and cytoplasmic Extraction Reagent (Pierce, Rockford,
IL, USA) in accordance with the manufacturer’s instructions. Protein concen-
tration was quantiﬁed by spectrophotometry using the BCA protein assay
(Pierce). For western blot analysis of TORC2, 15 lg of nuclear or cytoplasmic
proteins were loaded and separated in a 6% Tris-glycine gel (Invitrogen) and
gels were run until the 50 kDa marker (Prestained protein ladder; Fermentas,
Inc., Glen Burnie, MD, USA) ran off the gel. A 10% gel was used for protein
separation for phospho-CREB. Proteins were transferred to a polyvinyl diﬂu-
oride membrane (GE Amersham Biosciences, Piscataway, NJ, USA), incubated
with 5% nonfat milk in 1 · Tris-buffered saline plus 0.05% Tween 20 (TBST)
for 1 h and incubated overnight at 4  C with anti-TORC2 (Calbiochem⁄EDM
Chemicals, Gibbstown, NJ, USA), at a dilution of 1 : 6000, or anti-phospho-
CREB (Ser133) (clone 10E9; Millipore, Billerica, MA, USA), at a dilution of
0.5 lg⁄ml. After washing with TBST, the membranes were incubated with a
horseradish peroxidase-conjugated donkey antirabbit IgG at a dilution of
1 : 10 000. Immunorective bands were visualised using ECL Plus TM
reagents (GE Amersham Biosciences) followed by exposure to BioMax MR
ﬁlm (Eastman Kodak; Rochester, NY, USA). After ﬁlm exposure, blots were
stripped and assayed for histone deacetylase 1 (HDAC1) and b-actin as a
loading control. The intensity of the phosho-CREB (43 kDa), TORC2 (85 kDa),
P-TORC2 (100 kDa), HDAC1 (62 kD) and b-actin (42 kDa) bands integrated
with the area was quantiﬁed using a computer image analysis system,
Image J (developed at the National Institutes of Health and freely available
at: http://rsb.info.nih.gov). Data points for each gene were then normalised
relative to the HDAC1 band in the respective sample. For each blot, samples
from rats treated with ACTH (time points 5–60 min) were analysed as fold-
inductions relative to time 0.
Statistical analysis
Statistical signiﬁcance of the differences between groups was calculated by
one-way ANOVA followed by Fisher protected least signiﬁcant difference post-
hoc test when appropriate. P £ 0.05 was considered statistically signiﬁcant.
Data are represented as the mean  SEM fold induction relative to t0 from
the values in the number of observations indicated as appropriate.
Results
Effect of ACTH injection on plasma levels of ACTH and
corticosterone
The time-course of effect of a single injection of ACTH (4 ng) on
plasma ACTH and corticosterone is shown in Fig. 1. ACTH and corti-
costerone levels in rats treated with methylprednisolone were low
before ACTH injection. A small, but not signiﬁcant, effect of the
ACTH treatment on plasma levels of ACTH was found
(F4,20 = 2.327; P = 0.101; Fig. 1A). By contrast, ACTH injection
induced an increase in corticosterone levels (F4,20 = 5.024;
P = 0.008; Fig. 1B) and this effect was signiﬁcant 5 min (P = 0.005)
and 15 min (P = 0.01) after injection.
Effect of acute ACTH on StAR and P450scc gene
transcription and mRNA accumulation
The time-course of the effect of a single ACTH injection (4 ng) on
the levels of primary transcript (hnRNA) and mRNA levels of the
rate limiting steroidogenic proteins StAR and P450scc is shown in
Fig. 2. A single injection of ACTH (4 ng) increased the levels of StAR
hnRNA (F4,21 = 3.007; P = 0.048) and this effect was signiﬁcant
15 min after ACTH injection (P = 0.016). This small dose of ACTH
had no signiﬁcant effect on the accumulation of StAR mRNA dur-
ing the time period studied (F4,21 = 0.263; P = 0.898).
There was also an increase in P450scc hnRNA levels
(F4,21 = 8.656; P = 0.00053) and this effect was signiﬁcant 15 min
after injection (P = 0.00027). Moreover, there was a trend towards
signiﬁcance 30 min after ACTH injection (P = 0.055). As observed
for StAR protein, ACTH had no effect on the accumulation of
P450scc mRNA (F4,21 = 0.874; P = 0.5).
Table 1. Primers Sequence.
RNA Target Primer Sequence (5¢ to 3¢)
hnRNA StAR Forward GCAGCAGCAACTGCAGCACTAC
Reverse GTGCCCCCGGAGACTCACCT
P450scc Forward TGTGTGTGTGACCCCAGGAGAC
Reverse CCCAGGTCCTGCTTGAGAGGCT
SIK1 Forward TGTCAAGGAATGAGCGAGTG
Reverse TGAACTCCGACATGATCACC
mRNA StAR Forward CTGGCAGGCATGGCCACACA
Reverse GGCAGCCACCCCTTGAGGTC
P450scc Forward TGCGAGGGTCCTAACCCGGA
Reverse ACCTTCCAGCAGGGGCACGA
SIK1 Forward CCTCAGCAGTCTGGAGGTTC
Reverse TAAGGGCTGAAGCGAACTGT
GAPDH Forward CCATCACTGCCACCCAGAAGA
Reverse GACACATTGGGGGTAGGAACA
StAR, steroidogenic acute regulatory protein; P450scc, cytochrome P450
side-chain cleavage; SIK1, salt-inducible kinase 1; GAPDH, glyceraldehyde
3-phosphate dehydrogenase.
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The ability of a small ACTH dose to induce phosphorylation of CREB
and activation of the CREB co-activator, TORC 2, in the rat adrenals
was investigated using western blotting (Fig. 3). The time-course of
effect of ACTH injection on nuclear P-CREB is shown in Fig. 3(A, B).
There was a signiﬁcant effect of ACTH treatment on nuclear levels
of P-CREB (F4,16 = 6.571; P = 0.0048). This effect was transient,
with a marked increase in nuclear P-CREB 5 min after ACTH injec-
tion (P = 0.001), and returned to levels not signiﬁcantly different
from basal by 15 min.
The time course of the effect of ACTH on nuclear accumulation
of TORC2 in the rat adrenals is shown in Fig. 3(A,C). Western blot
analysis of TORC2 in adrenal nuclear and cytoplasmic proteins
revealed bands from approximately 85 to 100 kDa corresponding to
the molecular size of dephosphorylated and phosphorylated forms
of TORC2, respectively (Fig. 3A). In the cytoplasm, there was a
predominant band of approximately 100 kDa (Fig. 3A). In the
nucleus, the 100-kDa band was very low, although there was an
increase of lower molecular size bands of approximately 85 and
95 kDa. Semiquantitative analysis of the 85-kDa band (nonphosph-
orylated TORC 2) revealed a time dependent increase (F4,16 = 3.315;
P = 0.048; Fig. 3C). This increase of nuclear TORC 2 was statistically
signiﬁcant 5 min after ACTH injection (P = 0.02) and returned to
levels not signiﬁcantly different from basal by 15 min. By contrast,
analysis of the 100-kDa band (phosphorylated TORC2) revealed no
signiﬁcant effect of ACTH treatment on cytoplasmic P-TORC2
(F4,16 = 0.342; P = 0.844).
Effect of ACTH on SIK1 gene transcription and mRNA
accumulation
The time-course of effect of ACTH injection on the TORC2 suppres-
sor kinase, SIK1 hnRNA levels is shown in Fig. 4. ACTH treatment
05
Time (min)
15 30 60 0 5
Time (min)
15 30 60
4
3 (A) (B)
3
5
hnRNA
mRNA
hnRNA
mRNA
*
*
2
2
1
1
0 0
S
t
A
R
/
G
A
P
D
H
 
(
f
o
l
d
 
c
h
a
n
g
e
)
P
4
5
0
s
c
c
/
G
A
P
D
H
 
(
f
o
l
d
 
c
h
a
n
g
e
)
Fig. 2. Time course of the effect of adrenocorticotrophic hormone (ACTH) on steroidogenic acute regulatory protein (StAR) and side-chain cleavage cyto-
chrome P450 (P450scc) hnRNA and mRNA levels in the rat adrenal. Data points are the mean  SEM of the values obtained from three or four rats per group
expressed as the fold-change compared to values before ACTH injection (t0). Primary transcript (hnRNA) of StAR (A) and P450scc (B) was elevated 15 min after
ACTH injection. No effect of ACTH on StAR and P450scc mature RNA (mRNA) was observed. *P < 0.05; **P < 0.0001 compared to t0.
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Fig. 1. Time course of the effect of adrenocorticotrophic hormone (ACTH) on plasma levels of ACTH and corticosterone. ACTH (A) and corticosterone (B) levels
are low in rats treated with methylprednisolone (250 lg⁄rat, i.v.) 2 h before ACTH injection (t0). Intravenous injection of synthetic ACTH (4 ng⁄rat, i.v.) results
in brief elevation of circulating ACTH, which leads to an increase in corticosterone levels, with a signiﬁcant increase 5 and 15 min after the injection. Data
points are the mean  SEM of the value obtained from three or four rats per group. *P < 0.01; **P < 0.005 compared to t0.
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(F4,21 = 3.945; P = 0.019) and this effect was signiﬁcant 15 min
after ACTH treatment (P = 0.004). There was also an effect on
mature SIK1 RNA (mRNA) (F4,21 = 3.735; P = 0.023) and this effect
was signiﬁcant 30 min after ACTH injection (P = 0.005).
Discussion
Glucocorticoid secretion in rats exhibits an ultradian rhythm char-
acterised by release of pulses of corticosterone from the adrenal
gland at a rate of one pulse per hour. Although increasing evidence
emphasise the importance of glucocorticoid pulsatility for HPA
responsiveness to stress (17) and for glucocorticoid receptor
(GR)-mediated gene transcription (5, 6), the dynamics of pulsatile
synthesis and secretion of corticosterone have not been studied.
The present study aimed to investigate the rapid effects (5–60 min)
of low doses of ACTH, mimicking ultradian pulses on adrenocortical
function. Furthermore, the use of intronic qRT-PCR to determine
changes in primary transcript allowed us to estimate rapid changes
in the transcriptional activity of genes involved in steroidogenesis.
The data obtaned clearly show that minor increases in plasma ACTH
induced rapid and transient increases of plasma corticosterone
resembling an ultradian pulse. This was paralleled by sequential
phosphorylation of CREB and nuclear translocation of TORC2,
increases of StAR and P450scc transcription, and an increase of
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Fig. 3. Time course of the effect of adrenocorticotrophic hormone (ACTH) on nuclear levels of phospho-cyclic AMP-response element-binding protein
(P-CREB) and nuclear and cytoplasmic levels of transducer of regulated CREB activity 2 (TORC2) in the rat adrenal. Data points are the mean  SEM of the
values obtained from three or four rats per group expressed as the fold-change compared to values before ACTH injection (t0). Gels for nuclear and cytoplas-
mic proteins were run simultaneously in the same electrophoresis apparatus. The dotted lines in (A) show the alignment of the bands in nuclear and cytoplas-
mic proteins according to the molecular size markers indicating the shift in migration of the bands. Nuclear levels of P-CREB were elevated 5 min after ACTH
injection (A, B). Nuclear levels of nonphosphorylated TORC2 (85-kDa band) were elevated 5 min after ACTH injection, whereas no effect of ACTH was observed
on phosphorylated TORC2 (100-kDa band) in the cytoplasm (A, C). *P < 0.05; **P < 0.001 compared to t0. HDAC1, histone deacetylase 1.
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on salt-inducible kinase 1 (SIK1) hnRNA and mRNA levels in the rat adrenal.
Data points are the mean  SEM of the values obtained from three or four
rats per group expressed as the fold-change compared to values before
ACTH injection (t0). Primary transcript and mature RNA (mRNA) of SIK1 were
elevated 15 and 30 min, respectively, after ACTH injection. *P < 0.005 com-
pared to t0. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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kinase, SIK1.
Previous investigations in vivo examining the long-term effects
of high ACTH doses have demonstrated the ability of ACTH to
induce the steroidogenic proteins StAR and P450scc (18, 19). In the
present study, the injection of a very small ACTH dose was sufﬁ-
cient to induce rapid increases in plasma corticosterone with char-
acteristics both of amplitude and duration comparable to an
endogenous corticosterone pulse (14). This effect of ACTH was evi-
dent despite the barely detectable increases in plasma ACTH.
Although it is possible that plasma levels reached higher levels
before the ﬁrst time point measured (5 min), the data indicate that
adrenal fasciculata cells are distinctively sensitive to small eleva-
tions in circulating ACTH.
The rapidity of this response is consistent with in vitro studies
demonstrating that ACTH can initiate corticosterone synthesis
within approximately 3 min (20–22). The time course of ACTH
induced changes in corticosterone levels and in transcription of
the steroidogenic enzymes was quite remarkable. Although corti-
costerone rapidly reached peak levels by 5 min, StAR and P450scc
hnRNA had not changed by this time and only peaked at 15 min.
By contrast to the lack of change in StAR or P450scc mRNA
within 60 min of injection of 4 ng ACTH in the present study, a
previous report by LeHoux et al. (18) described a delayed increase
in StAR mRNA after 30 min of a larger dose of ACTH. Thus, it is
likely that smaller increases in mRNA synthesis in the present
study were masked by rapid mRNA turnover as a result of trans-
lation of pre-existing mRNA. On the other hand, the measurement
of hnRNA in the present study revealed increases in StAR and
P450scc transcription after these minor increases in circulating
ACTH. Although rapid, it is also clear that transcriptional activa-
tion does not precede corticosterone synthesis and secretion.
What is evident from both studies is that newly synthesised and
released corticosterone following ACTH injection must depend
upon ACTH-induced post-transcriptional (likely translational and
post-translational) changes of steroidogenic proteins rather than
the transcriptional response. Thus, newly transcribed hnRNA would
serve to restore steady-state mRNA pools. In this regard, ACTH
has been shown to modulate post-translational modiﬁcation of
StAR protein via proteolytic processing (23) and phosphorylation
(24).
Another remarkable ﬁnding was that nuclear levels of phospho
CREB and its co-activator, TORC2, increased within 5 min of the
injection of ACTH, well before the change in StAR and P450scc
transcription, and was already declining by 15 min. The impor-
tance of TORC2 translocation to the nucleus in steroidogenesis
has been previously suggested by in vitro studies in cell lines
demonstrating that the kinase inhibitor, staurosporin (known
to inhibit SIK1 and induce TORC2 translocation to the nucleus)
up-regulates the expression of steroidogenic proteins (13). The
present study provides the ﬁrst demonstration that minor rises in
circulating ACTH, capable of mediating ultradian pulses of gluco-
corticoids, cause rapid increases in the 85-kDa band corresponding
to dephosphorylated TORC2 in the nucleus, which precedes tran-
scriptional activation of StAR and P450scc. Although the western
blot clearly shows the more rapid migration of the nuclear bands
compared with the highly phosphorylated cytoplasmic bands
(Fig. 3A), slower migration bands were also present in the nuclear
fractions. The 100-kDa band, which was very weak and did no
change after ACTH, may correspond to cytoplasmic protein con-
tamination in the nuclear fractions. The identity of the 95-kDa
band is less clear and it is likely to correspond to partially phos-
phorylated forms. In this regard, it was recently reported that, in
addition to Ser 171, SIK1 phosphorylates TORC2 also at Ser 307,
and phosphorylation at this site inhibits nuclear localisation of
TORC2 (25). Therefore, it is possible that the p-TORC2 band
observed in the present study represents phospho-Ser171⁄dephos-
pho-Ser307-nuclear-TORC2.
Nuclear translocation of TORC2 is initiated by PKA-dependent
phosphorylation of SIK1 at Ser577, leading to its inactivation (26).
SIK1 is responsible for maintaining the TORC2 phosphorylation at
Ser
171 and Ser
275. In its phosphorylated form, TORC2 is transcrip-
tionally inactive and remains in the cytoplasm bound to the scaf-
folding protein 14-3-3. Thus, ACTH-mediated activation of PKA
would initiate StAR and P450scc transcription through CREB phos-
phorylation and simultaneous inactivation of SIK1, inhibiting
TORC2 phosphorylation and allowing its translocation to the
nucleus.
Interestingly, consistent with studies demonstrating the rapid
induction of SIK1 by cAMP in the steroidogenic cell line Y1 (27)
and rat pinealocytes (28), ACTH also induced SIK1 transcription and
mRNA. Although mRNA levels do not directly relate with the levels
of SIK1 protein or its inactive⁄active state by phosphoryla-
tion⁄dephosphorylation, the dynamic changes in expression induced
by the ACTH injection supports the proposal that SIK1 plays an
important role in the control of steroidogenesis.
The evidence suggesting that ACTH is able to both inactivate (via
cAMP-PKA mediated phosphorylation) and induce SIK1 raises the
exciting possibility that ACTH mediated inactivation and activation
of SIK1 could be part of an intracellular feedback mechanism
responsible for pulse generation in the adrenal cortex.
In summary, the data obtained in the present study clearly dem-
onstrate that small elevations of circulating ACTH by a single i.v.
injection in methylprednisolone-suppressed rats induce a pulse of
corticosterone of amplitude and duration similar to physiological
ultradian peaks. The parallel changes in StAR and P450scc tran-
scription suggest that pulsatility involves the dynamic regulation of
steroidogenic proteins. Although the signalling pathways leading to
SIK1 activation and the role of SIK1 on the termination of tran-
scription are currently under investigation, it is tempting to specu-
late that, concomitant with phosphorylating CREB, ACTH-mediated
PKA activation will initially inhibit SIK1 by phosphorylation and then
induce it, resulting in a biphasic change in SIK1 activity. This pro-
cess would result in a pulse of CREB-activated gene transcription
of both StAR and P450scc hnRNA.
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